Top Markets
Coin of the day
Verici Dx plc Verici Dx plc

Verici Dx plc

VRCI
株式のランク #41055
Verici Dx plc is an immuno-diagnostics company primarily focused on the kidney... Verici Dx plc is an immuno-diagnostics company primarily focused on the kidney transplantation sector. The firm specializes in creating both predictive and diagnostic assays for patients who have undergone kidney transplants. Its development pipeline features Clarava, a pre-transplant tool designed to forecast the likelihood of early acute rejection; Tuteva, a post-transplant assessment focusing on acute cellular rejection; and Protega, an innovative liquid biopsy aiming to predict the risk of fibrosis and eventual graft failure. Established in 2020, Verici Dx plc maintains its headquarters in Penarth, United Kingdom.
株価
$0.00285747
時価総額
$47.76K
変化(1日)
-16.00%
変化(1年)
-59.77%
GB
取引 Verici Dx plc (VRCI)

カテゴリー

Verici Dx plc(VRCI)の配当利回りの履歴
Verici Dx plc(銘柄コード: VRCI)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Verici Dx plc(VRCI)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)